FOCUS-Biotech-for-hire PeptiDream charts new path and becomes short target
November 13, 2019 at 08:58 AM EST
The promise of PeptiDream Inc's drug-discovery technology and its lucrative research-for-hire contracts have made it a darling of the Tokyo stock market. Now, those gains have made it a target for short-seller Muddy Waters.
